Pulmonx Corporation
LUNG
$1.58
-$0.01-0.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.86M | 22.54M | 23.77M | 20.39M | 20.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.86M | 22.54M | 23.77M | 20.39M | 20.78M |
| Cost of Revenue | 6.66M | 6.20M | 6.18M | 5.36M | 5.48M |
| Gross Profit | 17.20M | 16.34M | 17.59M | 15.03M | 15.31M |
| SG&A Expenses | 26.70M | 26.15M | 27.01M | 25.41M | 25.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.66M | 37.10M | 37.18M | 34.52M | 36.41M |
| Operating Income | -14.80M | -14.56M | -13.42M | -14.13M | -15.62M |
| Income Before Tax | -15.00M | -14.31M | -13.14M | -13.95M | -15.24M |
| Income Tax Expenses | 177.00K | 135.00K | 38.00K | 192.00K | 84.00K |
| Earnings from Continuing Operations | -15.17M | -14.45M | -13.18M | -14.14M | -15.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.17M | -14.45M | -13.18M | -14.14M | -15.33M |
| EBIT | -14.80M | -14.56M | -13.42M | -14.13M | -15.62M |
| EBITDA | -14.51M | -14.29M | -13.12M | -13.73M | -15.22M |
| EPS Basic | -0.38 | -0.36 | -0.33 | -0.36 | -0.39 |
| Normalized Basic EPS | -0.23 | -0.22 | -0.21 | -0.22 | -0.24 |
| EPS Diluted | -0.38 | -0.36 | -0.33 | -0.36 | -0.39 |
| Normalized Diluted EPS | -0.23 | -0.22 | -0.21 | -0.22 | -0.24 |
| Average Basic Shares Outstanding | 40.43M | 39.95M | 39.58M | 39.28M | 38.94M |
| Average Diluted Shares Outstanding | 40.43M | 39.95M | 39.58M | 39.28M | 38.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |